Abstract

Introduction/aimsPatients with diabetic polyneuropathy (DPN) may experience paresthesia, dysesthesia, and pain. We aimed to characterize the predictors, symptoms, somatosensory profile, neuropathy severity, and impact of painful DPN and dysesthetic DPN.MethodsThis study was a cross-sectional study of type 2 diabetes patients with confirmed DPN, diagnosed using widely accepted methods including a clinical examination, skin biopsy, and nerve conduction studies.FindingsOf 126 patients with confirmed DPN, 52 had DPN without pain or dysesthesia, 21 had dysesthetic DPN, and 53 painful DPN. Patients with painful DPN were less physically active and suffered from more pain elsewhere than in the feet compared to patients with DPN without pain. Patients with painful DPN had the largest loss of small and large sensory fiber function, and there was a gradient of larger spatial distribution of sensory loss from DPN without dysesthesia/pain to dysesthetic DPN and to painful DPN. This could indicate that patients with dysesthesia had more severe neuropathy than patients without dysesthesia but less than patients with painful DPN. Patients with dysesthetic and painful DPN had higher symptom scores for depression and fatigue than those without dysesthesia/pain with no difference between dysesthetic and painful DPN.ConclusionsThere was a gradient of increasing sensory loss from DPN without dysesthesia/pain to dysesthetic DPN and to painful DPN. Pain and dysesthesia are common in DPN and both interfere with daily life. It is therefore important to consider dysesthesia when diagnosing and treating patients with neuropathy.

Highlights

  • Diabetic polyneuropathy (DPN) is one of the most common complications to type 2 diabetes, affecting up to 50% of the patients [1]

  • There was a gradient of increasing sensory loss from DPN without dysesthesia/pain to dysesthetic DPN and to painful DPN

  • Pain and dysesthesia are common in DPN and both interfere with daily life

Read more

Summary

Introduction

Diabetic polyneuropathy (DPN) is one of the most common complications to type 2 diabetes, affecting up to 50% of the patients [1]. Patients with lesions or disease of the somatosensory nerve system may experience spontaneuous or evoked sensations ranging from paresthesia (an abnormal sensation) over dysesthesia (an unpleasant abnormal sensation, wheter spontaneous or evoked) to pain, which is defined as an unpleasant sensory and emotional experiences associated with, or resembling that associated with, actual or potential tissue damage [9, 10]. These symptoms are well-characterized in central neurological disorders. We have separated pain and dysesthesia in the present study

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.